Dottorato in NETWORK ONCOLOGY AND PRECISION MEDICINE

Ricerca: Le applicazioni di Network Medicine per la diagnosi precoce del carcinoma della prostata

PECORARO MARTINA

martina.pecoraro@uniroma1.it

ORCID: https://orcid.org/0000-0001-5180-7865

ESPERIENZA LAVORATIVA

Novembre 2018 – Ottobre 2022
Dipartimento di Scienze Radiologiche, Oncologia e Patologia, Università Sapienza - Policlinico Umberto I, Viale Regina Elena 324, Roma, Italia
Specializzando in Radiologia

ESPERIENZA DI RICERCA

2016 – in corso
Dipartimento di Scienze Radiologiche, Oncologia e Patologia, Università Sapienza - Policlinico Umberto I, Viale Regina Elena 324, Roma, Italia
Assistente di Ricerca

ISTRUZIONE E FORMAZIONE

2022 – in corso
Università Sapienza di Roma
Network Oncology e Precision Medicine
Dottorato di Ricerca

2011-2017
Università Sapienza di Roma, Scuola Internazionale di Medicina
Laurea in Medicina
Medico Chirurgo

NOMINE INTERNAZIONALI
2023-in corso: Membro della Società Europea di Imaging Urogenitale (ESUI) dell'Associazione Europea di Urologia (EAU)
2022-2023: Membro del Comitato di Ricerca della Società Europea di Radiologia (ESR)
2022-in corso: Membro della Rete Junior della Società Europea di Oncologia Urogenitale (ESUR), Rappresentante del gruppo di lavoro KUB
2020-2023: Membro del Consiglio del Forum dei Specializzandi in Radiologia (RTF) della Società Europea di Radiologia (ESR)
2020-2023: Assessore Junior del Programma di Valutazione della Formazione Europea (ETAP), Comitato Scientifico dell'European Board of Radiology (EBR)

COMPETENZE PERSONALI E PROFESSIONALI
Costruzione di relazioni collaborative
Pensiero critico e forte etica del lavoro
Molto motivato e laborioso, sia individualmente che come parte di un team

LINGUA MATERNA: ITALIANO

ALTRE LINGUE: INGLESE

COMPETENZE ORGANIZZATIVE
Gestione di pazienti all'interno di team multidisciplinari
Stesura di progetti di ricerca

COMPETENZE TECNICHE
Uso di software di diagnostica (IA e Radiomica)

CONFERENZE COME RELATORE
Congresso Europeo di Radiologia (ECR), 2018-2019-2020-2021 (online) -2022, 2023
Radiological Society of North America (RSNA), 2019-2021-2022, 2023
Società Italiana di Radiologia Medica (SIRM), 2022, 2023
International Society for Magnetic Resonance in Medicine (ISMRM) – Sezione Italiana, 2019-2021
Associazione Europea di Urologia (EAU), 2018-2022
Società Europea di Oncologia Urogenitale (ESUR), 2017-2022, 2023
Società Italiana di Urologia Oncologica (SIUrO), 2017
Società Europea di Imaging Urogenitale (ESUI), 2023

ATTIVITÀ SCIENTIFICA E PRODUZIONE
AREA DI RICERCA:
Risonanza Magnetica (con focus sulla patologia oncologica prostatica e vescicale)
Tomografia Computerizzata (con focus sulla patologia renale, postelaborazione delle immagini)
Network Medicine per la Ricerca sul carcinoma della prostata
Articoli pubblicati: 43 Capitoli di Libri Pubblicati: 2
Indice H: 14 (Scopus)

PUBBLICAZIONI SCIENTIFICHE

1: Pecoraro M, Takeuchi M, Vargas HA, Muglia VF, Cipollari S, Catalano C,
Panebianco V. Overview of VI-RADS in Bladder Cancer. AJR Am J Roentgenol. 2020
Jun;214(6):1259-1268. doi: 10.2214/AJR.20.22763. Epub 2020 Apr 14. PMID:
32286874.

2: Messina E, Pisciotti ML, Pecoraro M, Borrelli A, Del Giudice F, Panebianco V.
The use of MRI in urothelial carcinoma. Curr Opin Urol. 2022 Sep
1;32(5):536-544. doi: 10.1097/MOU.0000000000001011. Epub 2022 Jul 15. PMID:
35849696.

3: Nicola R, Pecoraro M, Lucciola S, Dos Reis RB, Narumi Y, Panebianco V, Muglia
VF. VI-RADS score system - A primer for urologists. Int Braz J Urol. 2022 Jul-
Aug;48(4):609-622. doi: 10.1590/S1677-5538.IBJU.2021.0560. PMID: 35195385;
PMCID: PMC9306377.

4: Caglic I, Panebianco V, Vargas HA, Bura V, Woo S, Pecoraro M, Cipollari S,
Sala E, Barrett T. MRI of Bladder Cancer: Local and Nodal Staging. J Magn Reson
Imaging. 2020 Sep;52(3):649-667. doi: 10.1002/jmri.27090. Epub 2020 Feb 29.
PMID: 32112505.

5: Messina E, Pecoraro M, Pisciotti ML, Del Giudice F, Lucciola S, Bicchetti M,
Laschena L, Roberto M, De Berardinis E, Franco G, Panebianco V. Seeing is
Believing: State of the Art Imaging of Bladder Cancer. Semin Radiat Oncol. 2023
Jan;33(1):12-20. doi: 10.1016/j.semradonc.2022.10.002. PMID: 36517189.

6: Panebianco V, Briganti A, Boellaard TN, Catto J, Comperat E, Efstathiou J,
van der Heijden AG, Giannarini G, Girometti R, Mertens L, Takeuchi M, Muglia VF,
Narumi Y, Novara G, Pecoraro M, Roupret M, Sanguedolce F, Santini D, Shariat SF,
Simone G, Vargas HA, Woo S, Barentsz J, Witjes JA. Clinical application of
bladder MRI and the Vesical Imaging-Reporting And Data System. Nat Rev Urol.
2023 Nov 30. doi: 10.1038/s41585-023-00830-2. Epub ahead of print. PMID:
38036666.

7: Panebianco V, Pecoraro M, Del Giudice F, Takeuchi M, Muglia VF, Messina E,
Cipollari S, Giannarini G, Catalano C, Narumi Y. VI-RADS for Bladder Cancer:
Current Applications and Future Developments. J Magn Reson Imaging. 2022
Jan;55(1):23-36. doi: 10.1002/jmri.27361. Epub 2020 Sep 17. PMID: 32939939.

8: Pecoraro M, Messina E, Bicchetti M, Carnicelli G, Del Monte M, Iorio B, La
Torre G, Catalano C, Panebianco V. The future direction of imaging in prostate
cancer: MRI with or without contrast injection. Andrology. 2021
Sep;9(5):1429-1443. doi: 10.1111/andr.13041. Epub 2021 Jun 8. PMID: 33998173.

9: Giganti F, Ng A, Asif A, Chan VW, Rossiter M, Nathan A, Khetrapal P,
Dickinson L, Punwani S, Brew-Graves C, Freeman A, Emberton M, Moore CM, Allen C,
Kasivisvanathan V; PRIME Quality Improvement Group. Global Variation in Magnetic
Resonance Imaging Quality of the Prostate. Radiology. 2023 Oct;309(1):e231130.
doi: 10.1148/radiol.231130. PMID: 37815448.

10: Panebianco V, Pecoraro M, Fiscon G, Paci P, Farina L, Catalano C. Prostate
cancer screening research can benefit from network medicine: an emerging
awareness. NPJ Syst Biol Appl. 2020 May 7;6(1):13. doi:
10.1038/s41540-020-0133-0. PMID: 32382028; PMCID: PMC7206063.

11: Cipollari S, Carnicelli G, Bicchetti M, Campa R, Pecoraro M, Panebianco V.
Utilization of imaging for staging in bladder cancer: is there a role for MRI or
PET-computed tomography? Curr Opin Urol. 2020 May;30(3):377-386. doi:
10.1097/MOU.0000000000000743. PMID: 32168196.

12: Del Giudice F, Flammia RS, Pecoraro M, Moschini M, D'Andrea D, Messina E,
Pisciotti LM, De Berardinis E, Sciarra A, Panebianco V. The accuracy of Vesical
Imaging-Reporting and Data System (VI-RADS): an updated comprehensive multi-
institutional, multi-readers systematic review and meta-analysis from diagnostic
evidence into future clinical recommendations. World J Urol. 2022
Jul;40(7):1617-1628. doi: 10.1007/s00345-022-03969-6. Epub 2022 Mar 16. PMID:
35294583; PMCID: PMC9237003.

13: Pecoraro M, Dehghanpour A, Das JP, Woo S, Panebianco V. Evaluation of
Prostate Cancer Recurrence with MR Imaging and Prostate Imaging for Recurrence
Reporting Scoring System. Radiol Clin North Am. 2024 Jan;62(1):135-159. doi:
10.1016/j.rcl.2023.06.013. Epub 2023 Aug 21. PMID: 37973239.

14: Leonardo C, Flammia RS, Lucciola S, Proietti F, Pecoraro M, Bucca B, Licari
LC, Borrelli A, Bologna E, Landini N, Del Monte M, Chung BI, Catalano C,
Magliocca FM, De Berardinis E, Del Giudice F, Panebianco V. Performance of Node-
RADS Scoring System for a Standardized Assessment of Regional Lymph Nodes in
Bladder Cancer Patients. Cancers (Basel). 2023 Jan 18;15(3):580. doi:
10.3390/cancers15030580. PMID: 36765540; PMCID: PMC9913205.

15: Messina E, Pecoraro M, Laschena L, Bicchetti M, Proietti F, Ciardi A,
Leonardo C, Sciarra A, Girometti R, Catalano C, Panebianco V. Low cancer yield
in PI-RADS 3 upgraded to 4 by dynamic contrast-enhanced MRI: is it time to
reconsider scoring categorization? Eur Radiol. 2023 Aug;33(8):5828-5839. doi:
10.1007/s00330-023-09605-0. Epub 2023 Apr 13. PMID: 37045981; PMCID:
PMC10326099.

16: Pecoraro M, Turkbey B, Purysko AS, Girometti R, Giannarini G, Villeirs G,
Roberto M, Catalano C, Padhani AR, Barentsz JO, Panebianco V. Diagnostic
Accuracy and Observer Agreement of the MRI Prostate Imaging for Recurrence
Reporting Assessment Score. Radiology. 2022 Aug;304(2):342-350. doi:
10.1148/radiol.212252. Epub 2022 May 10. PMID: 35536130.

17: da Silva MC, Pecoraro M, Pisciotti ML, Dehghanpour A, Forookhi A, Lucciola
S, Bicchetti M, Messina E, Catalano C, Panebianco V. The learning curve in
bladder MRI using VI-RADS assessment score during an interactive dedicated
training program. Eur Radiol. 2022 Nov;32(11):7494-7503. doi:
10.1007/s00330-022-08766-8. Epub 2022 Apr 2. PMID: 35366122; PMCID: PMC8976109.

18: Cipollari S, Guarrasi V, Pecoraro M, Bicchetti M, Messina E, Farina L, Paci
P, Catalano C, Panebianco V. Convolutional Neural Networks for Automated
Classification of Prostate Multiparametric Magnetic Resonance Imaging Based on
Image Quality. J Magn Reson Imaging. 2022 Feb;55(2):480-490. doi:
10.1002/jmri.27879. Epub 2021 Aug 9. PMID: 34374181; PMCID: PMC9291235.

19: Girometti R, Giannarini G, Panebianco V, Maresca S, Cereser L, De Martino M,
Pizzolitto S, Pecoraro M, Ficarra V, Zuiani C, Valotto C. Comparison of
different thresholds of PSA density for risk stratification of PI-RADSv2.1
categories on prostate MRI. Br J Radiol. 2022 Mar 1;95(1131):20210886. doi:
10.1259/bjr.20210886. Epub 2021 Nov 11. PMID: 34762506; PMCID: PMC8978227.

20: Pecoraro M, Del Giudice F, Magliocca F, Simone G, Flammia S, Leonardo C,
Messina E, De Berardinis E, Cortesi E, Panebianco V. Vesical Imaging-Reporting
and Data System (VI-RADS) for assessment of response to systemic therapy for
bladder cancer: preliminary report. Abdom Radiol (NY). 2022 Feb;47(2):763-770.
doi: 10.1007/s00261-021-03365-5. Epub 2021 Dec 17. PMID: 34919160.

21: Pecoraro M, Cipollari S, Marchitelli L, Messina E, Del Monte M, Galea N,
Ciardi MR, Francone M, Catalano C, Panebianco V. Cross-sectional analysis of
follow-up chest MRI and chest CT scans in patients previously affected by
COVID-19. Radiol Med. 2021 Oct;126(10):1273-1281. doi:
10.1007/s11547-021-01390-4. Epub 2021 Jul 12. PMID: 34251585; PMCID: PMC8274263.

22: Bicchetti M, Simone G, Giannarini G, Girometti R, Briganti A, Brunocilla E,
Cardone G, De Cobelli F, Gaudiano C, Del Giudice F, Flammia S, Leonardo C,
Pecoraro M, Schiavina R, Catalano C, Panebianco V. A novel pathway to detect
muscle-invasive bladder cancer based on integrated clinical features and VI-RADS
score on MRI: results of a prospective multicenter study. Radiol Med. 2022
Aug;127(8):881-890. doi: 10.1007/s11547-022-01513-5. Epub 2022 Jun 28. PMID:
35763251; PMCID: PMC9349064.

23: Del Giudice F, van Uem S, Li S, Vilson FL, Sciarra A, Salciccia S, Busetto
GM, Maggi M, Tiberia L, Viscuso P, Canale V, Panebianco V, Pecoraro M, Ferro M,
Moschini M, Krajewski W, D'Andrea D, Cacciamani GE, Mari A, Soria F, Porpiglia
F, Fiori C, Amparore D, Checcucci E, Autorino R, De Berardinis E, Chung BI.
Contemporary Trends of Systemic Neoadjuvant and Adjuvant Intravesical
Chemotherapy in Patients With Upper Tract Urothelial Carcinomas Undergoing
Minimally Invasive or Open Radical Nephroureterectomy: Analysis of US Claims on
Perioperative Outcomes and Health Care Costs. Clin Genitourin Cancer. 2022
Apr;20(2):198.e1-198.e9. doi: 10.1016/j.clgc.2021.11.016. Epub 2021 Dec 24.
PMID: 35031226.

24: Del Monte M, Cipollari S, Del Giudice F, Pecoraro M, Bicchetti M, Messina E,
Dehghanpour A, Ciardi A, Sciarra A, Catalano C, Panebianco V. MRI-directed
biopsy for primary detection of prostate cancer in a population of 223 men: MRI
In-Bore vs MRI-transrectal ultrasound fusion-targeted techniques. Br J Radiol.
2022 Mar 1;95(1131):20210528. doi: 10.1259/bjr.20210528. Epub 2021 Oct 5. PMID:
34609900; PMCID: PMC8978234.

25: Cipollari S, Pecoraro M, Forookhi A, Laschena L, Bicchetti M, Messina E,
Lucciola S, Catalano C, Panebianco V. Biparametric prostate MRI: impact of a
deep learning-based software and of quantitative ADC values on the inter-reader
agreement of experienced and inexperienced readers. Radiol Med. 2022
Nov;127(11):1245-1253. doi: 10.1007/s11547-022-01555-9. Epub 2022 Sep 17. PMID:
36114928; PMCID: PMC9587977.

26: European Society of Radiology (ESR). Impact of COVID-19 on radiology
education in Europe: a survey by the ESR Radiology Trainees Forum (RTF).
Insights Imaging. 2021 Nov 9;12(1):165. doi: 10.1186/s13244-021-01113-3. PMID:
34751827; PMCID: PMC8576794.

27: Stanzione A, Hornia EA, Moreira ASL, Russo L, Andrieu PC, Carnelli C,
Cuocolo R, Brembilla G, Zawaideh JP; ESUR Junior Network Committee.
Dissemination of endometrial cancer MRI staging guidelines among young
radiologists: an ESUR Junior Network survey. Insights Imaging. 2023 Sep
4;14(1):143. doi: 10.1186/s13244-023-01491-w. PMID: 37667135; PMCID:
PMC10477141.

28: Campa R, Del Monte M, Barchetti G, Pecoraro M, Salvo V, Ceravolo I, Indino
EL, Ciardi A, Catalano C, Panebianco V. Improvement of prostate cancer detection
combining a computer-aided diagnostic system with TRUS-MRI targeted biopsy.
Abdom Radiol (NY). 2019 Jan;44(1):264-271. doi: 10.1007/s00261-018-1712-z. PMID:
30054684.

29: Del Monte M, Leonardo C, Salvo V, Grompone MD, Pecoraro M, Stanzione A,
Campa R, Vullo F, Sciarra A, Catalano C, Panebianco V. MRI/US fusion-guided
biopsy: performing exclusively targeted biopsies for the early detection of
prostate cancer. Radiol Med. 2018 Mar;123(3):227-234. doi:
10.1007/s11547-017-0825-8. Epub 2017 Oct 26. Erratum in: Radiol Med. 2018 Jan
9;: PMID: 29075977.

30: Panebianco V, Paci P, Pecoraro M, Conte F, Carnicelli G, Besharat ZM,
Catanzaro G, Splendiani E, Sciarra A, Farina L, Catalano C, Ferretti E. Network
Analysis Integrating microRNA Expression Profiling with MRI Biomarkers and
Clinical Data for Prostate Cancer Early Detection: A Proof of Concept Study.
Biomedicines. 2021 Oct 14;9(10):1470. doi: 10.3390/biomedicines9101470. PMID:
34680592; PMCID: PMC8533640.

31: Pecoraro M, Panebianco V. Multiparametric Prostate MRI for Biochemical
Failure in the Era of Targeted PET Radiotracers: Counterpoint-MRI Remains a
Specific and Accessible Test for Targeted Management. AJR Am J Roentgenol. 2023
Feb;220(2):188-189. doi: 10.2214/AJR.22.28042. Epub 2022 Jun 1. PMID: 35642757.

32: Giganti F, Pecoraro M, Fierro D, Campa R, Del Giudice F, Punwani S, Kirkham
A, Allen C, Emberton M, Catalano C, Moore CM, Panebianco V. DWI and PRECISE
criteria in men on active surveillance for prostate cancer: A multicentre
preliminary experience of different ADC calculations. Magn Reson Imaging. 2020
Apr;67:50-58. doi: 10.1016/j.mri.2019.12.007. Epub 2019 Dec 30. PMID: 31899283.

33: Messina E, Proietti F, Laschena L, Flammia RS, Pecoraro M, Cipollari S,
Simone G, Catalano C, Leonardo C, Panebianco V. MRI for risk stratification of
muscle invasion by upper tract urothelial carcinoma: a feasibility study. Eur
Radiol Exp. 2024 Jan 19;8(1):9. doi: 10.1186/s41747-023-00403-3. PMID: 38238523;
PMCID: PMC10796856.

34: Giganti F, Pecoraro M, Stavrinides V, Stabile A, Cipollari S, Sciarra A,
Kirkham A, Allen C, Punwani S, Emberton M, Catalano C, Moore CM, Panebianco V.
Interobserver reproducibility of the PRECISE scoring system for prostate MRI on
active surveillance: results from a two-centre pilot study. Eur Radiol. 2020
Apr;30(4):2082-2090. doi: 10.1007/s00330-019-06557-2. Epub 2019 Dec 16. PMID:
31844959; PMCID: PMC7062656.

35: Forookhi A, Laschena L, Pecoraro M, Borrelli A, Massaro M, Dehghanpour A,
Cipollari S, Catalano C, Panebianco V. Bridging the experience gap in prostate
multiparametric magnetic resonance imaging using artificial intelligence: A
prospective multi-reader comparison study on inter-reader agreement in PI-RADS
v2.1, image quality and reporting time between novice and expert readers. Eur J
Radiol. 2023 Apr;161:110749. doi: 10.1016/j.ejrad.2023.110749. Epub 2023 Feb 19.
PMID: 36812699.

36: Borrelli A, Pecoraro M, Del Giudice F, Cristofani L, Messina E, Dehghanpour
A, Landini N, Roberto M, Perotti S, Muscaritoli M, Santini D, Catalano C,
Panebianco V. Standardization of Body Composition Status in Patients with
Advanced Urothelial Tumors: The Role of a CT-Based AI-Powered Software for the
Assessment of Sarcopenia and Patient Outcome Correlation. Cancers (Basel). 2023
May 29;15(11):2968. doi: 10.3390/cancers15112968. PMID: 37296930; PMCID:
PMC10251974.

37: Del Giudice F, Pecoraro M, Vargas HA, Cipollari S, De Berardinis E,
Bicchetti M, Chung BI, Catalano C, Narumi Y, Catto JWF, Panebianco V. Systematic
Review and Meta-Analysis of Vesical Imaging-Reporting and Data System (VI-RADS)
Inter-Observer Reliability: An Added Value for Muscle Invasive Bladder Cancer
Detection. Cancers (Basel). 2020 Oct 15;12(10):2994. doi:
10.3390/cancers12102994. PMID: 33076505; PMCID: PMC7602537.

38: Del Giudice F, Leonardo C, Simone G, Pecoraro M, De Berardinis E, Cipollari
S, Flammia S, Bicchetti M, Busetto GM, Chung BI, Gallucci M, Catalano C,
Panebianco V. Preoperative detection of Vesical Imaging-Reporting and Data
System (VI-RADS) score 5 reliably identifies extravesical extension of
urothelial carcinoma of the urinary bladder and predicts significant delayed
time to cystectomy: time to reconsider the need for primary deep transurethral
resection of bladder tumour in cases of locally advanced disease? BJU Int. 2020
Nov;126(5):610-619. doi: 10.1111/bju.15188. Epub 2020 Aug 17. PMID: 32783347.

39: Del Giudice F, Barchetti G, De Berardinis E, Pecoraro M, Salvo V, Simone G,
Sciarra A, Leonardo C, Gallucci M, Catalano C, Catto JWF, Panebianco V.
Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS)
and Its Clinical Impact on the Management of High-risk Non-muscle-invasive
Bladder Cancer Patients Candidate for Repeated Transurethral Resection. Eur
Urol. 2020 Jan;77(1):101-109. doi: 10.1016/j.eururo.2019.09.029. Epub 2019 Nov
5. PMID: 31699526.

40: Messina E, La Torre G, Pecoraro M, Pisciotti ML, Sciarra A, Poscia R,
Catalano C, Panebianco V. Design of a magnetic resonance imaging-based screening
program for early diagnosis of prostate cancer: preliminary results of a
randomized controlled trial-Prostate Cancer Secondary Screening in Sapienza
(PROSA). Eur Radiol. 2024 Jan;34(1):204-213. doi: 10.1007/s00330-023-10019-1.
Epub 2023 Aug 10. PMID: 37561183.

41: Pecoraro M, Catanzaro G, Conte F, Besharat ZM, Messina E, Laschena L,
Trocchianesi S, Splendiani E, Sciarra A, Catalano C, Paci P, Ferretti E,
Panebianco V. Prospective Validation Study of a Novel Integrated Pathway Based
on Clinical Features, Magnetic Resonance Imaging Biomarkers, and MicroRNAs for
Early Detection of Prostate Cancer. Eur Urol Oncol. 2024 Feb;7(1):73-82. doi:
10.1016/j.euo.2023.05.008. Epub 2023 Jun 1. PMID: 37270379.

42: Panebianco V, Valerio MC, Giuliani A, Pecoraro M, Ceravolo I, Barchetti G,
Catalano C, Padhani AR. Clinical Utility of Multiparametric Magnetic Resonance
Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate
Cancer. Eur Urol Oncol. 2018 Aug;1(3):208-214. doi: 10.1016/j.euo.2018.03.008.
Epub 2018 May 15. PMID: 31102623.

43: Del Monte M, Leonardo C, Salvo V, Grompone MD, Pecoraro M, Stanzione A,
Campa R, Vullo F, Sciarra A, Catalano C, Panebianco V. Correction to: MRI/US
fusion-guided biopsy: performing exclusively targeted biopsies for the early
detection of prostate cancer. Radiol Med. 2018 Mar;123(3):235. doi:
10.1007/s11547-017-0852-5. Erratum for: Radiol Med. 2018 Mar;123(3):227-234.
PMID: 29318440.

AFFILIAZIONI SCIENTIFICHE
Società Italiana di Radiologia Medica (SIRM)
European Society of Radiology (ESR)
European Society of Urogenital Oncology (ESUR)
Radiological Society of North America (RSNA)

PREMI E FINANZIAMENTI
2023 - RADIOLOGY RISING STAR AWARD - AUNTMINNIE
2022 - BORSA DI RICERCA DELL'UNIVERSITÀ DI SAPIENZA (PROGETTO DI RICERCA)
2022 - ECR 2022 – PREMIO PER LA MIGLIORE PRESENTAZIONE DI RICERCA GENITOURINARIA
2021 - BORSA DI RICERCA DELL'UNIVERSITÀ DI SAPIENZA (PROGETTO DI RICERCA)
2019 - BORSA DI RICERCA DELL'UNIVERSITÀ DI SAPIENZA (PROGETTO DI RICERCA)
2017 - ESUR, PREMIO PER LA MIGLIORE PRESENTAZIONE ORALE, SESSIONE DEI MEMBRI
2017 - SIURO, PREMIO PER IL MIGLIOR POSTER
2016 - CIRSE, PREMIO PER LA MIGLIORE PERFORMANCE NEL TEST INTERNAZIONALE DEGLI STUDENTI